Courage Against Cancer
At Courage Against Cancer (CAC), we believe every cancer patient deserves honest, evidence-based answers to the most pressing questions — including this one. Fenbendazole, a veterinary anthelmintic, has generated significant interest through anecdotal stories, but mainstream oncology has not yet endorsed it.
At Courage Against Cancer (CAC), we know that cancer patients are searching for every evidence-informed option available — including repurposed drugs like fenbendazole that are generating real scientific curiosity. Bringing these topics to your oncologist can feel intimidating, but open communication matters.
At Courage Against Cancer (CAC), we believe patients deserve evidence-based answers to the real questions they’re asking — including whether human clinical trials on fenbendazole for colorectal cancer exist in 2026. The short answer: formal, large-scale human trials remain extremely limited.
If you are a colorectal cancer patient considering fenbendazole, the most important first step is an honest, open conversation with your oncologist before starting anything. Evidence-based answers to this question consistently point to the same priority: protect your proven treatment plan while …